Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Goodwill & Intangibles (2023 - 2025)

Connect Biopharma Holdings (CNTB) has disclosed Goodwill & Intangibles for 3 consecutive years, with $45000.0 as the latest value for Q4 2025.

  • Quarterly Goodwill & Intangibles fell 15.09% to $45000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $45000.0 through Dec 2025, down 15.09% year-over-year, with the annual reading at $45000.0 for FY2025, 15.09% down from the prior year.
  • Goodwill & Intangibles hit $45000.0 in Q4 2025 for Connect Biopharma Holdings, down from $47000.0 in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $62000.0 in Q4 2023 to a low of $45000.0 in Q4 2025.
  • Historically, Goodwill & Intangibles has averaged $50833.3 across 3 years, with a median of $49000.0 in 2025.
  • Biggest five-year swings in Goodwill & Intangibles: fell 14.52% in 2024 and later decreased 15.09% in 2025.
  • Year by year, Goodwill & Intangibles stood at $62000.0 in 2023, then fell by 14.52% to $53000.0 in 2024, then dropped by 15.09% to $45000.0 in 2025.
  • Business Quant data shows Goodwill & Intangibles for CNTB at $45000.0 in Q4 2025, $47000.0 in Q3 2025, and $48000.0 in Q2 2025.